dual DNA gyrase/topoisomerase IV inhibitors (Roche Holdings/MicuRx Pharmaceuticals/WuXi AppTec)

N/A

Report date: 2025/03/19 09:01:46
NME

Base Information

Drug Namedual DNA gyrase/topoisomerase IV inhibitors (Roche Holdings/MicuRx Pharmaceuticals/WuXi AppTec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRoche Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMicuRx Pharmaceutical IncRoche Holding LtdWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A